Next-generation mt-sDNA test shows higher sensitivity but lower specificity compared to FIT for CRC screening.
Blood tests show promise for colorectal cancer screening, but colonoscopy remains the gold standard.
Blood-based screening for colorectal cancer is not as effective or cost-effective as established methods like colonoscopy.
Starting colorectal cancer screening at age 50 is recommended by the American College of Physicians.
Blood-based biomarker tests may revolutionize colorectal cancer screening, potentially replacing colonoscopies in the future.